Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.

Tien YT, Chang MH, Chu PY, Lin CS, Liu CH, Liao AT.

Vet J. 2015 Jan 5. pii: S1090-0233(14)00529-2. doi: 10.1016/j.tvjl.2014.12.031. [Epub ahead of print]

PMID:
25616642
2.

Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.

Chiang HC, Liao AT, Jan TR, Wang YS, Lei HJ, Tsai MH, Chen MF, Lee CY, Lin YC, Chu RM, Lin CS.

Vet Immunol Immunopathol. 2013 Feb 15;151(3-4):207-16. doi: 10.1016/j.vetimm.2012.11.009. Epub 2012 Nov 21.

PMID:
23237908
3.

Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor.

Chiang HC, Wang YS, Chou CH, Liao AT, Chu RM, Lin CS.

BMC Vet Res. 2012 Nov 9;8:216. doi: 10.1186/1746-6148-8-216.

4.

KIT gene exon 11 mutations in canine malignant melanoma.

Chu PY, Pan SL, Liu CH, Lee J, Yeh LS, Liao AT.

Vet J. 2013 May;196(2):226-30. doi: 10.1016/j.tvjl.2012.09.005. Epub 2012 Oct 13.

PMID:
23069279
5.

Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.

Chu PY, Hsu NC, Liao AT, Shih NY, Hou MF, Liu CH.

BMC Vet Res. 2011 Oct 21;7:62. doi: 10.1186/1746-6148-7-62.

6.

Elevated Krüppel-like factor 4 transcription factor in canine mammary carcinoma.

Chu PY, Hsu NC, Liao AT, Yeh KT, Hou MF, Liu CH.

BMC Vet Res. 2011 Oct 7;7:58. doi: 10.1186/1746-6148-7-58.

7.

A 12-year retrospective study of canine testicular tumors.

Liao AT, Chu PY, Yeh LS, Lin CT, Liu CH.

J Vet Med Sci. 2009 Jul;71(7):919-23.

8.

Characterization of STAT3 activation and expression in canine and human osteosarcoma.

Fossey SL, Liao AT, McCleese JK, Bear MD, Lin J, Li PK, Kisseberth WC, London CA.

BMC Cancer. 2009 Mar 10;9:81. doi: 10.1186/1471-2407-9-81.

9.

A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.

Liao AT, McCleese J, Kamerling S, Christensen J, London CA.

Vet Comp Oncol. 2007 Sep;5(3):177-96. doi: 10.1111/j.1476-5829.2007.00137.x.

PMID:
19754789
10.

Identification of a novel germline MET mutation in dogs.

Liao AT, McMahon M, London CA.

Anim Genet. 2006 Jun;37(3):248-52.

PMID:
16734685
11.

Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.

Zavodovskaya R, Liao AT, Jones CL, Yip B, Chien MB, Moore PF, London CA.

Am J Vet Res. 2006 Apr;67(4):633-41.

PMID:
16579756
12.

Characterization, expression and function of c-Met in canine spontaneous cancers.

Liao AT, McMahon M, London C.

Vet Comp Oncol. 2005 Jun;3(2):61-72. doi: 10.1111/j.1476-5810.2005.00067.x.

PMID:
19379214
13.

Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors.

Liao AT, Chien MB, Shenoy N, Mendel DB, McMahon G, Cherrington JM, London CA.

Blood. 2002 Jul 15;100(2):585-93. Erratum in: Blood 2002 Oct 15;100(8):2696.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk